PARK AVENUE SECURITIES LLC

Broker-Dealer

Position in ARGX — Argenx SE

CIK 1071640 NEW YORK, NY

Position in ARGX

as of Jun 30, 2026 · filed Jul 20, 2026 Compact

Position Value

$886,948

-$16,371 QoQ

Shares Held

956

-22.7% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#259

of 504 holders

Holding Since

Sep 2023

12 quarters on record

Healthcare · as of Jun 30, 2026

PARK AVENUE SECURITIES LLC holds $18,019,918 across 22 Biotechnology names. ARGX ranks #6 (4.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	10,198	$5,065,652
2	RPRX	Royalty Pharma plc	46,965	$2,633,327
3	INSM	INSMED Inc	9,927	$1,058,416
4	REGN	Regeneron Pharmaceuticals, Inc.	1,563	$974,593
5	EXEL	Exelixis, Inc.	16,542	$900,050
6	ARGX	Argenx SE This page	956	$886,948
7	JAZZ	Jazz Pharmaceuticals plc	3,608	$869,419
8	HALO	Halozyme Therapeutics, Inc.	10,089	$789,666

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$886,948	956	-22.7%	Shares	Sole	2026-07-20
2026-03-31	$903,319	1,237	-35.8%	Shares	Sole	2026-04-07
2025-12-31	$1,621,351	1,928	-9.8%	Shares	Sole	2026-01-05
2025-09-30	$1,576,165	2,137	+10.4%	Shares	Sole	2025-10-23
2025-06-30	$1,067,161	1,936	+7.3%	Shares	Sole	2025-07-14
2025-03-31	$1,067,724	1,804	+6.4%	Shares	Sole	2025-04-14
2024-12-31	$1,042,425	1,695	+40.0%	Shares	Sole	2025-01-14
2024-09-30	$656,458	1,211	-8.5%	Shares	Sole	2024-10-03
2024-06-30	$569,372	1,324	+7.2%	Shares	Sole	2024-07-09
2024-03-31	$486,244	1,235	+20.7%	Shares	Sole	2024-04-10
2023-12-31	$389,179	1,023	+19.6%	Shares	Sole	2024-01-10
2023-09-30	$420,343	855	—	Shares	Sole	2023-10-26
No filing history on record for this holder in this stock.